Brevilin A is a potent anti-metastatic CRC agent that targets the VEGF-IL6-STAT3 axis in the HSCs-CRC interplay

[1]  Hong-Yang Wang,et al.  Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells , 2022, Acta Pharmacologica Sinica.

[2]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[3]  A. Papavassiliou,et al.  Targeting STAT3 Signaling Pathway in Colorectal Cancer , 2021, Biomedicines.

[4]  T. Sim,et al.  Natural and Synthetic Lactones Possessing Antitumor Activities , 2021, International journal of molecular sciences.

[5]  D. Steinhilber,et al.  The Emerging Therapeutic Potential of Nitro Fatty Acids and Other Michael Acceptor-Containing Drugs for the Treatment of Inflammation and Cancer , 2020, Frontiers in Pharmacology.

[6]  J. Niu,et al.  Interleukin-6 Promotes Epithelial-Mesenchymal Transition and Cell Invasion through Integrin β6 Upregulation in Colorectal Cancer , 2020, Oxidative medicine and cellular longevity.

[7]  J. Tabernero,et al.  Clinical development of therapies targeting TGFβ: current knowledge and future perspectives. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  W. Tai,et al.  Synthesis and Evaluation of Novel Anticancer Compounds Derived from the Natural Product Brevilin A , 2020, ACS omega.

[9]  K. Zhou,et al.  CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer , 2019, Cancer biology & therapy.

[10]  Yue-Ting K Lau,et al.  Targeting STAT3 in Cancer with Nucleotide Therapeutics , 2019, Cancers.

[11]  T. Kamiyama,et al.  IL6 Modulates the Immune Status of the Tumor Microenvironment to Facilitate Metastatic Colonization of Colorectal Cancer Cells , 2019, Cancer Immunology Research.

[12]  W. Tai,et al.  Brevilin A Induces Cell Cycle Arrest and Apoptosis in Nasopharyngeal Carcinoma , 2019, Front. Pharmacol..

[13]  J. C. Schmitz,et al.  Targeting colon cancer with the novel STAT3 inhibitor bruceantinol , 2018, Oncogene.

[14]  Gang Yang,et al.  Tumor microenvironment participates in metastasis of pancreatic cancer , 2018, Molecular Cancer.

[15]  Zachary T. Giaccone,et al.  IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment. , 2018, Cancer research.

[16]  Jennifer R. Grandis,et al.  Targeting the IL-6/JAK/STAT3 signalling axis in cancer , 2018, Nature Reviews Clinical Oncology.

[17]  Hezhen Wu,et al.  Brevilin A induces apoptosis and autophagy of colon adenocarcinoma cell CT26 via mitochondrial pathway and PI3K/AKT/mTOR inactivation. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  L. Ellis,et al.  Intracrine VEGF signalling mediates colorectal cancer cell migration and invasion , 2017, British Journal of Cancer.

[19]  B. Luxon,et al.  Vascular endothelial growth factor promotes the activation of hepatic stellate cells in chronic schistosomiasis , 2017, Immunology and cell biology.

[20]  Hiroki Takahashi,et al.  High serum levels of interleukin-6 in patients with advanced or metastatic colorectal cancer: the effect on the outcome and the response to chemotherapy plus bevacizumab , 2017, Surgery Today.

[21]  P. Brodt.  Role of the Microenvironment in Liver Metastasis: From Pre- to Prometastatic Niches , 2016, Clinical Cancer Research.

[22]  N. Munshi,et al.  Review of siltuximab in the treatment of multicentric Castleman’s disease , 2016, Therapeutic advances in hematology.

[23]  G. Helmlinger,et al.  A Generic Mechanism for Enhanced Cytokine Signaling via Cytokine-Neutralizing Antibodies , 2016, PloS one.

[24]  E. Laurini,et al.  Hitting the right spot: Mechanism of action of OPB‐31121, a novel and potent inhibitor of the Signal Transducer and Activator of Transcription 3 (STAT3) , 2015, Molecular oncology.

[25]  Y. Bang,et al.  Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors , 2015, Cancer research and treatment : official journal of Korean Cancer Association.

[26]  Jiwang Zhang,et al.  Osteopontin Mediates an MZF1-TGF-β1-Dependent Transformation of Mesenchymal Stem Cells into Cancer Associated Fibroblasts in Breast Cancer , 2014, Oncogene.

[27]  Toshio Tanaka,et al.  IL-6 in inflammation, immunity, and disease. , 2014, Cold Spring Harbor perspectives in biology.

[28]  I. Nagtegaal,et al.  Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  J. Machiels,et al.  A Phase I/II, Multiple-Dose, Dose-Escalation Study of Siltuximab, an Anti-Interleukin-6 Monoclonal Antibody, in Patients with Advanced Solid Tumors , 2014, Clinical Cancer Research.

[30]  W. Mesker,et al.  Interaction with colon cancer cells hyperactivates TGF-β signaling in cancer-associated fibroblasts , 2014, Oncogene.

[31]  A. G. de Herreros,et al.  Functional Heterogeneity of Cancer-Associated Fibroblasts from Human Colon Tumors Shows Specific Prognostic Gene Expression Signature , 2013, Clinical Cancer Research.

[32]  Xiaodong Qin,et al.  Brevilin A, a Novel Natural Product, Inhibits Janus Kinase Activity and Blocks STAT3 Signaling in Cancer Cells , 2013, PloS one.

[33]  Jing-Yuan Fang,et al.  Inhibition of JAK2/STAT3 signalling induces colorectal cancer cell apoptosis via mitochondrial pathway , 2012, Journal of cellular and molecular medicine.

[34]  G. Gores,et al.  Hepatic stellate cells: Partners in crime for liver metastases? , 2011, Hepatology.

[35]  R. Vatsyayan,et al.  The sensors and regulators of cell–matrix surveillance in anoikis resistance of tumors , 2011, International journal of cancer.

[36]  L. Ellis,et al.  Intracrine Vascular Endothelial Growth Factor Signaling in Survival and Chemoresistance of Human Colorectal Cancer Cells , 2010, Oncogene.

[37]  Marian Brennan,et al.  Integrins as therapeutic targets: lessons and opportunities , 2010, Nature Reviews Drug Discovery.

[38]  Ken Kato,et al.  Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer. , 2009, Japanese journal of clinical oncology.

[39]  Hidekazu Takagi,et al.  Hepatic Stellate Cells Promote Liver Metastasis of Colon Cancer Cells by the Action of SDF-1/CXCR4 Axis , 2009, Annals of Surgical Oncology.

[40]  A. Bosserhoff,et al.  Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma , 2009, Cancer science.

[41]  U. Gehling,et al.  Tumorigenesis and Neoplastic Progression Stromal Fibroblasts in Colorectal Liver Metastases Originate From Resident Fibroblasts and Generate an Inflammatory Microenvironment , 2010 .

[42]  Erik Sahai,et al.  Illuminating the metastatic process , 2007, Nature Reviews Cancer.

[43]  Gholam Basati,et al.  Interleukin-6 level in patients with colorectal cancer. , 2006, Cancer letters.

[44]  Yuan‐Chiang Chung,et al.  Clinical significance of tissue expression of interleukin-6 in colorectal carcinoma. , 2006, Anticancer research.

[45]  Georg Bartsch,et al.  Interleukin‐6 regulation of prostate cancer cell growth , 2005, Journal of cellular biochemistry.

[46]  M. Kuo,et al.  A novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth. , 2005, Cancer research.

[47]  Kurt Zatloukal,et al.  Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. , 2005, Neoplasia.

[48]  Yuan-Chang Chung,et al.  Significance of inflammatory cytokines in the progression of colorectal cancer. , 2003, Hepato-gastroenterology.

[49]  Yuan‐Chang Chung,et al.  Serum interleukin‐6 levels reflect the disease status of colorectal cancer , 2003, Journal of surgical oncology.

[50]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[51]  T. Sawada,et al.  In vivo and in vitro Interactions between Human Colon Carcinoma Cells and Hepatic Stellate Cells , 2000, Japanese journal of cancer research : Gann.

[52]  T. Hirano,et al.  Signaling mechanisms through gp130: a model of the cytokine system. , 1997, Cytokine & growth factor reviews.